<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-nutrients-11-00333" class="ref">
 <label class="label">59.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Thandavarayan</surname>
    <given-names class="given-names">R.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Giridharan</surname>
    <given-names class="given-names">V.V.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Arumugam</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Suzuki</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ko</surname>
    <given-names class="given-names">K.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Krishnamurthy</surname>
    <given-names class="given-names">P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Watanabe</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Konishi</surname>
    <given-names class="given-names">T.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/P53 signaling</article-title>
  <source class="source">PLoS ONE</source>
  <year class="year">2015</year>
  <volume class="volume">10</volume>
  <elocation-id class="elocation-id">e0119214</elocation-id>
  <pub-id pub-id-type="doi" class="pub-id">10.1371/journal.pone.0119214</pub-id>
  <?supplied-pmid 25742619?>
  <pub-id pub-id-type="pmid" class="pub-id">25742619</pub-id>
 </element-citation>
</ref>
